Janus Henderson Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,051,077
| Closed | -$107M | – | 2609 |
|
|
2023
Q2 | $107M | Buy |
1,051,077
+827,758
| +371% | +$84.4M | 0.07% | 248 |
|
|
2023
Q1 | $20.3M | Buy |
223,319
+217,947
| +4,057% | +$19.8M | 0.01% | 576 |
|
|
2022
Q4 | $204K | Buy |
+5,372
| New | +$204K | ﹤0.01% | 2177 |
|
|
2021
Q2 | – | Sell |
-71,876
| Closed | -$7.17M | – | 1694 |
|
|
2021
Q1 | $7.17M | Buy |
71,876
+22,285
| +45% | +$2.22M | ﹤0.01% | 951 |
|
|
2020
Q4 | $6.13M | Buy |
+49,591
| New | +$6.13M | ﹤0.01% | 928 |
|